Shah, T.U. et al. 2012. Pilot Study of Aprepitant for Prevention of Post-ERCP Pancreatitis in High Risk Patients: A Phase II Randomized, Double-Blind Placebo Controlled Trial. JOP. Journal of the Pancreas. 13, 5 (Sep. 2012), 514–518. DOI:https://doi.org/10.6092/1590-8577/855.